Vitarka Therapeutics
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
160 City Rd, London, Greater London, EC1...Website
www.vitarka.co.ukRevenue
<$5 MillionIndustry
About Vitarka Therapeutics
Is Vitarka Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Vitarka Therapeutics
Product Launch: Get notified when Vitarka Therapeutics launches new products
Click to see if Vitarka Therapeutics had a recent Job posting/layoffs
Check if Vitarka Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Vitarka Therapeutics is spiking on competitors!
Vitarka Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Vitarka Therapeutics has new funding data
Earning: See what the market has to say on Vitarka Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Vitarka Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Vitarka Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vitarka Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vitarka Therapeutics.
Vitarka Therapeutics Tech Stack
A closer look at the technologies used by Vitarka Therapeutics
Top Business Services Companies
Frequently Asked Questions Regarding Vitarka Therapeutics
Vitarka Therapeutics Ltd is a pre-clinical biotech company focused on combating late-stage cancers. The company has developed an innovative intracellular drug delivery technology called EndoPore, which utilizes pore forming proteins to target intracellular sites. Their primary aim is to treat cancer by effectively delivering potent therapeutics to... Read More